Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Heritage Cannabis Holdings Corp TRJTF


Primary Symbol: HERTF

Heritage Cannabis Holdings Corp. is a Canada-based cannabis company offering products to both the medical and recreational legal cannabis markets in Canada and the United States. It focuses on extraction and the creation of extract and extract-derivative products and brands for adult use and cannabis-based medical solutions. It has a portfolio of cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, Thrifty, Adults Only, feelgood., the CB4 suite of medical products in Canada and ArthroCBD in the United States. In Canada, it operates through its subsidiaries, Heritage Cannabis West Corporation (Heritage West) and Heritage Cannabis East Corporation (Heritage East). Heritage West holds a Health Canada issued cultivation, processing, and medical and adult use sales license, as well as an industrial hemp license, a cannabis oil sales license, and a cannabis research license. In the United States, it operates through, Opticann Inc., an oral and topical cannabinoid company.


PINL:HERTF - Post by User

Comment by PumperStalkeron Oct 16, 2018 12:11am
27 Views
Post# 28807432

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Pumpy...Can you please tell us where you see bullsh*t ?

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Pumpy...Can you please tell us where you see bullsh*t ?Sorry to interject but you may have misread something.

For Purefarma I used 33 million shares.

It's not shares..

It's units which means that there are warrants attched which could either double the count or if the unit includes a half share it can add another 50% to the count. :)



VENMan wrote: Bobgreenfield, this is how I came up with my numbers:

So I used 200 Million current shares outstanding for CANN

For CannaCure I took 100 million shares plus 33 million unit’s conversion to shares and for Capex and Opex I used $7.5 million needed at 30 cents per share is 25 million shares assumed financing.

For Purefarma I used 33 million shares.

Add it all up and you get 391 million shares. Then I rounded up to 400 million shares.

Then you still have to find money for working capital and I assumed $100 million at $1 per share for an additional 100 million shares and got to 500 million shares but perhaps other sources of financing like a debenture could be used or perhaps a financing for only $50 million or less would work for fewer shares outstanding but taking 100 million shares which is a lot the share price could still be north of a buck. I would rather assume more shares than less shares outstanding. All IMO!    
  
Used following Sources from CANN News releases:

Under the terms of the agreement, shareholders of CannaCure will receive 100 million shares of Heritage with an additional 33 million units subject to an escrow release upon certain milestones in exchange for 100-per-cent ownership of CannaCure to Heritage. The transaction is scheduled to close on or before Sept. 28, 2018, and is subject to several conditions including the completion of due diligence, a definitive agreement, regulatory approval, as well as Heritage obtaining a minimum of $7.5-million for expansion purposes.

Under the terms of this arm's-length agreement, shareholders of Purefarma will receive 33,333,333 shares of Heritage at a cost base of 30 cents per share, resulting in the Purefarma shareholders owning 14 per cent of the issued and outstanding shares of Heritage. Additionally, they have a potential to earn 16 million shares subject to an earnout based upon certain gross margin milestones achieved on an annual basis over the next four years. 



Bullboard Posts